CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT(3-4a)N(0-1)M(0)) (NCT03001596)

BACKGROUND: Neoadjuvant chemoradiation is not recommended as an approach for treatment of esophageal squamous cell carcinoma due to its significant postoperative mortality. However, it is assumed the combination of neoadjuvant chemoradiation with minimally invasive esophagectomy (MIE) may reduce pos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Tang, Han, Tan, Lijie, Shen, Yaxing, Wang, Hao, Lin, Miao, Feng, Mingxiang, Xu, Songtao, Guo, Weigang, Qian, Cheng, Liu, Tianshu, Zeng, Zhaochong, Hou, Yingyong, Yu, Zhentao, Jiang, Hongjing, Li, Zhigang, Chen, Chun, Lian, Changhong, Du, Ming, Li, Hecheng, Xie, Deyao, Yin, Jun, Zhao, Naiqing, Wang, Qun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490174/
https://ncbi.nlm.nih.gov/pubmed/28659128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3446-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados